REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,373,121 | +23.7% | 40,080 | +10.0% | 0.01% | +20.0% |
Q2 2023 | $5,152,115 | +100.0% | 36,421 | +138.0% | 0.01% | +66.7% |
Q1 2023 | $2,575,908 | -48.9% | 15,300 | -48.6% | 0.00% | -40.0% |
Q4 2022 | $5,041,882 | -50.6% | 29,779 | -45.4% | 0.01% | -58.3% |
Q3 2022 | $10,196,000 | +19.8% | 54,492 | +4.0% | 0.01% | +20.0% |
Q2 2022 | $8,510,000 | +0.6% | 52,402 | +16.5% | 0.01% | +25.0% |
Q1 2022 | $8,459,000 | -22.7% | 44,969 | +8.8% | 0.01% | -11.1% |
Q4 2021 | $10,948,000 | +39.9% | 41,339 | +52.7% | 0.01% | +50.0% |
Q3 2021 | $7,823,000 | +158.4% | 27,070 | +73.8% | 0.01% | +100.0% |
Q1 2021 | $3,028,000 | -62.0% | 15,576 | -62.5% | 0.00% | -57.1% |
Q4 2020 | $7,967,000 | -54.5% | 41,574 | -64.9% | 0.01% | -61.1% |
Q3 2020 | $17,495,000 | +444.8% | 118,581 | +356.4% | 0.02% | +350.0% |
Q2 2020 | $3,211,000 | -34.8% | 25,980 | -49.1% | 0.00% | -50.0% |
Q1 2020 | $4,923,000 | -59.0% | 50,998 | -60.7% | 0.01% | -38.5% |
Q4 2019 | $11,997,000 | +32.1% | 129,691 | +9.5% | 0.01% | +18.2% |
Q3 2019 | $9,084,000 | -50.4% | 118,459 | -44.4% | 0.01% | -52.2% |
Q2 2019 | $18,305,000 | +17.4% | 212,970 | -19.3% | 0.02% | +15.0% |
Q1 2019 | $15,595,000 | +10.9% | 263,971 | -1.0% | 0.02% | +5.3% |
Q4 2018 | $14,062,000 | +576.1% | 266,630 | +611.0% | 0.02% | +850.0% |
Q3 2018 | $2,080,000 | +593.3% | 37,502 | +352.9% | 0.00% | – |
Q1 2018 | $300,000 | -77.7% | 8,280 | -77.6% | 0.00% | -100.0% |
Q4 2017 | $1,343,000 | +386.6% | 37,019 | +413.7% | 0.00% | – |
Q3 2017 | $276,000 | -88.4% | 7,206 | -87.5% | 0.00% | -100.0% |
Q2 2017 | $2,387,000 | +84.5% | 57,601 | +56.7% | 0.00% | +100.0% |
Q1 2017 | $1,294,000 | +7.2% | 36,760 | -6.1% | 0.00% | 0.0% |
Q4 2016 | $1,207,000 | +220.2% | 39,149 | +213.8% | 0.00% | +100.0% |
Q3 2016 | $377,000 | -19.3% | 12,474 | -28.4% | 0.00% | 0.0% |
Q1 2016 | $467,000 | -25.4% | 17,424 | -44.9% | 0.00% | 0.0% |
Q4 2014 | $626,000 | -67.1% | 31,600 | -67.0% | 0.00% | -50.0% |
Q3 2014 | $1,905,000 | -11.4% | 95,700 | +1.5% | 0.00% | -33.3% |
Q2 2014 | $2,149,000 | -5.9% | 94,300 | -46.9% | 0.00% | 0.0% |
Q1 2014 | $2,283,000 | +183.6% | 177,504 | +200.4% | 0.00% | +200.0% |
Q4 2013 | $805,000 | +132.7% | 59,091 | +89.6% | 0.00% | 0.0% |
Q3 2013 | $346,000 | – | 31,167 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
Miura Global Management | 85,000 | $24,564,000 | 3.81% |
Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |